Sivik Global Healthcare’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-45,000
| Closed | -$4.32M | – | 42 |
|
|
2025
Q4 | $4.32M | Sell |
45,000
-15,000
| -25% | -$1.46M | 1.25% | 27 |
|
|
2025
Q3 | $5.71M | Sell |
60,000
-20,000
| -25% | -$1.84M | 1.66% | 23 |
|
|
2025
Q2 | $6.97M | Buy |
80,000
+5,000
| +7% | +$424K | 1.9% | 21 |
|
|
2025
Q1 | $6.74M | Buy |
+75,000
| New | +$6.71M | 3.64% | 11 |
|
|
2024
Q4 | – | Sell |
-60,000
| Closed | -$5.4M | – | 43 |
|
|
2024
Q3 | $5.4M | Buy |
+60,000
| New | +$5.05M | 2.29% | 19 |
|
|
2024
Q1 | – | Sell |
-80,000
| Closed | -$6.59M | – | 52 |
|
|
2023
Q4 | $6.59M | Hold |
80,000
| – | – | 2.75% | 13 |
|
|
2023
Q3 | $6.27M | Buy |
80,000
+20,000
| +33% | +$1.67M | 3.17% | 16 |
|
|
2023
Q2 | $5.29M | Sell |
60,000
-7,500
| -11% | -$646K | 1.24% | 27 |
|
|
2023
Q1 | $5.44M | Buy |
+67,500
| New | +$5.5M | 2.34% | 21 |
|
|
2022
Q4 | – | Sell |
-30,000
| Closed | -$2.42M | – | 45 |
|
|
2022
Q3 | $2.42M | Sell |
30,000
-10,000
| -25% | -$899K | 1.35% | 33 |
|
|
2022
Q2 | $3.59M | Buy |
40,000
+5,000
| +14% | +$507K | 2.04% | 28 |
|
|
2022
Q1 | $3.88M | Buy |
+35,000
| New | +$3.7M | 1.6% | 29 |
|
|
2021
Q4 | – | Sell |
-80,000
| Closed | -$10M | – | 51 |
|
|
2021
Q3 | $10M | Hold |
80,000
| – | – | 2.4% | 9 |
|
|
2021
Q2 | $9.93M | Hold |
80,000
| – | – | 1.94% | 9 |
|
|
2021
Q1 | $9.45M | Hold |
80,000
| – | – | 3.45% | 4 |
|
|
2020
Q4 | $9.37M | Buy |
80,000
+10,000
| +14% | +$1.1M | 3.82% | 5 |
|
|
2020
Q3 | $7.27M | Buy |
70,000
+10,000
| +17% | +$1M | 3.13% | 15 |
|
|
2020
Q2 | $5.5M | Buy |
+60,000
| New | +$5.75M | 1.82% | 24 |
|
|
2020
Q1 | – | Sell |
-45,000
| Closed | -$5.11M | – | 54 |
|
|
2019
Q4 | $5.11M | Buy |
45,000
+5,000
| +13% | +$549K | 1.9% | 32 |
|
|
2019
Q3 | $4.34M | Buy |
40,000
+10,000
| +33% | +$1.04M | 2.19% | 26 |
|
|
2019
Q2 | $2.92M | Buy |
+30,000
| New | +$2.74M | 0.71% | 46 |
|
|
2017
Q3 | – | Sell |
-35,000
| Closed | -$3.11M | – | 82 |
|
|
2017
Q2 | $3.11M | Buy |
+35,000
| New | +$2.95M | 1.14% | 36 |
|
|
2016
Q4 | – | Sell |
-65,000
| Closed | -$5.62M | – | 61 |
|
|
2016
Q3 | $5.62M | Buy |
65,000
+5,000
| +8% | +$436K | 2.83% | 16 |
|
|
2016
Q2 | $5.21M | Buy |
60,000
+15,000
| +33% | +$1.21M | 2.59% | 10 |
|
|
2016
Q1 | $3.38M | Hold |
45,000
| – | – | 1.49% | 31 |
|
|
2015
Q4 | $3.46M | Hold |
45,000
| – | – | 1.64% | 28 |
|
|
2015
Q3 | $3.01M | Buy |
45,000
+500
| +1% | +$36.8K | 1.46% | 27 |
|
|
2015
Q2 | $3.3M | Sell |
44,500
-30,500
| -41% | -$2.33M | 1.14% | 33 |
|
|
2015
Q1 | $5.85M | Buy |
+75,000
| New | +$5.68M | 1.99% | 13 |
|
Other funds holding MDT
VCM
VPM
Sivik Global Healthcare's MDT Position: Q1 2026 in Review
Sivik Global Healthcare sold out of Medtronic (MDT) in Q1 2026, closing a stake of 45,000 shares — an estimated $4.32M sold.
Sivik Global Healthcare first reported a position in MDT in Q1 2015 and held it in 29 quarters. The position peaked at $10M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Sivik Global Healthcare reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
- Sivik Global Healthcare sold 45,000 Medtronic shares in Q1 2026, an estimated $4.32M.
- Sivik Global Healthcare first reported a position in Medtronic in Q1 2015 and held it in 29 quarters.
- Sivik Global Healthcare's Medtronic position peaked at $10M in Q3 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Sivik Global Healthcare's 13F filing for Q1 2026, filed 15 Apr 2026.